HYDRALAZINE HYDROCHLORIDE

HYDRALAZINE HYDROCHLORIDE was reported 2674 times

HYDRALAZINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GINGIVAL POLYP 4 0.3636
1 PULMONARY RENAL SYNDROME 82 0.2350
2 HEART FAILURE WITH PRESERVED EJECTION FRACTION 66 0.2245
3 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 433 0.1750
4 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY 16 0.1739
5 CENTRAL NERVOUS SYSTEM LUPUS 38 0.1704
6 BODY MASS INDEX ABNORMAL 37 0.1516
7 PATHERGY REACTION 3 0.1071
8 ENTEROCOLITIS FUNGAL 3 0.1000
9 LUPUS PNEUMONITIS 10 0.0893
10 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 93 0.0829
11 MICROSPORIDIA INFECTION 27 0.0769
12 SEROSITIS 41 0.0741
13 RENAL VASCULITIS 17 0.0530
14 LUPUS PLEURISY 2 0.0500
15 GLOMERULONEPHRITIS PROLIFERATIVE 16 0.0443
16 MITRAL VALVE HYPOPLASIA 2 0.0426
17 LUPUS NEPHRITIS 74 0.0395
18 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 10 0.0368
19 STEM CELL THERAPY 2 0.0339
20 GLOMERULONEPHRITIS 80 0.0327
21 BURKHOLDERIA TEST POSITIVE 4 0.0323
22 HYPERPLASIA ADRENAL 2 0.0317
23 UPPER GASTROINTESTINAL PERFORATION 2 0.0317
24 SHONE COMPLEX 2 0.0294
25 ANTINUCLEAR ANTIBODY NEGATIVE 1 0.0286
26 LUPUS VASCULITIS 3 0.0278
27 LOSS OF EMPLOYMENT 73 0.0241
28 POLYSEROSITIS 10 0.0235
29 GLIOSIS 10 0.0233
30 PNEUMOCYSTIS JIROVECII INFECTION 27 0.0226
31 VENTRICULAR HYPERKINESIA 2 0.0225
32 DIFFUSE VASCULITIS 2 0.0222
33 AUTOIMMUNE PANCYTOPENIA 2 0.0220
34 ARTERIAL PERFORATION 1 0.0200
35 PRIMARY HYPERALDOSTERONISM 3 0.0192
36 BULLOUS HAEMORRHAGIC DERMATOSIS 4 0.0190
37 OVARIAN FAILURE 10 0.0187
38 ACTION TREMOR 3 0.0185
39 VASCULITIS GASTROINTESTINAL 2 0.0182
40 ARTERIOVENOUS GRAFT SITE INFECTION 1 0.0179
41 NEUTROPHILIC DERMATOSIS 7 0.0177
42 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 41 0.0176
43 PERFUME SENSITIVITY 10 0.0176
44 RETINOPATHY HYPERTENSIVE 5 0.0165
45 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 4 0.0159
46 VASCULITIS NECROTISING 10 0.0140
47 INTESTINAL METAPLASIA 2 0.0138
48 AUTOIMMUNE NEPHRITIS 3 0.0136
49 LUPUS-LIKE SYNDROME 123 0.0135
50 MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS 2 0.0131
51 CONGENITAL AORTIC VALVE STENOSIS 2 0.0129
52 HISTONE ANTIBODY POSITIVE 2 0.0128
53 ANTINUCLEAR ANTIBODY 2 0.0127
54 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 9 0.0123
55 ANTI-ERYTHROCYTE ANTIBODY POSITIVE 1 0.0122
56 PHLEBOLITH 2 0.0118
57 POUCHITIS 10 0.0116
58 PULMONARY ALVEOLAR HAEMORRHAGE 62 0.0110
59 PROCTECTOMY 3 0.0109
60 PREMATURE MENOPAUSE 10 0.0108
61 CONGENITAL AORTIC ANOMALY 2 0.0107
62 VENTILATION PERFUSION MISMATCH 3 0.0107
63 PRIMARY BILIARY CHOLANGITIS 5 0.0106
64 MASTOCYTOSIS 5 0.0106
65 EOSINOPHILIC PLEURAL EFFUSION 3 0.0101
66 CONGENITAL AORTIC STENOSIS 2 0.0099
67 NEPHRITIC SYNDROME 3 0.0097
68 COMA SCALE ABNORMAL 27 0.0093
69 PULMONARY VASCULITIS 5 0.0093
70 SOMATIC SYMPTOM DISORDER 10 0.0093
71 RENAL FAILURE NEONATAL 2 0.0090
72 OVERLAP SYNDROME 6 0.0086
73 CONGENITAL HEART VALVE DISORDER 2 0.0084
74 AORTA HYPOPLASIA 2 0.0077
75 PLEUROPERICARDITIS 3 0.0073
76 VACCINATION SITE PAIN 4 0.0070
77 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
78 ANTIPHOSPHOLIPID SYNDROME 10 0.0062
79 RHYTHM IDIOVENTRICULAR 2 0.0062
80 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED 1 0.0060
81 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 2 0.0057
82 HEMIANOPIA HOMONYMOUS 4 0.0055
83 HEPATIC STEATOSIS 97 0.0052
84 COARCTATION OF THE AORTA 5 0.0052
85 URINARY CASTS 2 0.0051
86 BICUSPID AORTIC VALVE 3 0.0051
87 VASCULITIS 58 0.0050
88 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 1 0.0048
89 MATERNAL EXPOSURE TIMING UNSPECIFIED 18 0.0048
90 TRANSFERRIN SATURATION DECREASED 2 0.0047
91 CARDIAC TAMPONADE 21 0.0044
92 VENOUS THROMBOSIS LIMB 9 0.0044
93 CRYPTOCOCCOSIS 7 0.0043
94 CUTANEOUS VASCULITIS 15 0.0041
95 BRAIN STEM STROKE 2 0.0041
96 ADENOTONSILLECTOMY 1 0.0040
97 CONJUNCTIVAL OEDEMA 4 0.0039
98 NEPHROGENIC ANAEMIA 18 0.0039
99 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
100 APPLICATION SITE MASS 1 0.0036
101 DISTRIBUTIVE SHOCK 8 0.0035
102 MALIGNANT HYPERTENSION 3 0.0035
103 RENAL TUBULAR INJURY 4 0.0033
104 HYPERPARATHYROIDISM SECONDARY 8 0.0032
105 GLUCOSE URINE PRESENT 4 0.0031
106 WAIST CIRCUMFERENCE INCREASED 3 0.0029
107 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
108 ANION GAP DECREASED 1 0.0029
109 RENAL APLASIA 2 0.0028
110 GRANULOMATOUS LIVER DISEASE 2 0.0028
111 ANGIODYSPLASIA 1 0.0027
112 CONTRAINDICATED PRODUCT ADMINISTERED 81 0.0027
113 MULTIPLE DRUG THERAPY 2 0.0027
114 GOUTY ARTHRITIS 2 0.0025
115 GOUT 45 0.0025
116 KETONURIA 2 0.0025
117 NEPHRITIS 8 0.0024
118 RENAL TUBULAR ATROPHY 2 0.0023
119 AZOTAEMIA 9 0.0023
120 VOCAL CORD PARALYSIS 4 0.0022
121 BODY MASS INDEX INCREASED 3 0.0022
122 NORMAL NEWBORN 12 0.0022
123 ESSENTIAL HYPERTENSION 4 0.0022
124 BLOOD PRESSURE INADEQUATELY CONTROLLED 13 0.0022
125 THERAPEUTIC PRODUCT EFFECT DECREASED 96 0.0021
126 BLOOD UREA ABNORMAL 2 0.0021
127 HAEMATURIA 70 0.0020
128 ARTERIOVENOUS FISTULA 1 0.0020
129 END STAGE RENAL DISEASE 37 0.0020
130 VENTRICULAR HYPERTROPHY 5 0.0020
131 ILEOSTOMY 5 0.0020
132 CORONAVIRUS TEST POSITIVE 2 0.0019
133 HYPOPERFUSION 2 0.0019
134 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3 0.0019
135 IRON OVERLOAD 2 0.0019
136 AMNIOTIC FLUID VOLUME DECREASED 1 0.0018
137 RETROPERITONEAL HAEMATOMA 4 0.0018
138 MEDICAL PROCEDURE 3 0.0018
139 TROPONIN I INCREASED 3 0.0018
140 PULMONARY HAEMORRHAGE 14 0.0018
141 DIFFUSE ALVEOLAR DAMAGE 2 0.0017
142 KIDNEY FIBROSIS 3 0.0017
143 GLOMERULONEPHRITIS MEMBRANOUS 2 0.0017
144 HYPERTENSIVE EMERGENCY 2 0.0017
145 MITRAL VALVE DISEASE 3 0.0017
146 RETINAL VASCULITIS 2 0.0017
147 ADRENAL ADENOMA 1 0.0017
148 CHRONIC RESPIRATORY FAILURE 2 0.0017
149 CARDIAC FAILURE CONGESTIVE 131 0.0016
150 ARTERITIS 1 0.0016
151 ANOXIC ENCEPHALOPATHY 1 0.0016
152 LIPOMA 4 0.0015
153 HYPERKALAEMIA 54 0.0015
154 LIP EXFOLIATION 2 0.0015
155 FOETAL GROWTH RESTRICTION 9 0.0015
156 PERICARDIAL EFFUSION 34 0.0015
157 SYSTEMIC LUPUS ERYTHEMATOSUS 52 0.0015
158 RHONCHI 2 0.0014
159 AUTOIMMUNE HEPATITIS 10 0.0014
160 THERAPEUTIC PROCEDURE 2 0.0014
161 LOW BIRTH WEIGHT BABY 11 0.0014
162 AORTIC VALVE SCLEROSIS 1 0.0014
163 DIABETIC NEPHROPATHY 3 0.0014
164 LIVER DISORDER 60 0.0014
165 CONJUNCTIVITIS ALLERGIC 2 0.0013
166 SKIN STRIAE 2 0.0013
167 GASTRIC DISORDER 46 0.0013
168 DIALYSIS 19 0.0013
169 METABOLIC ENCEPHALOPATHY 4 0.0013
170 PARANASAL SINUS DISCOMFORT 5 0.0013
171 PREMATURE DELIVERY 21 0.0013
172 THERAPEUTIC PRODUCT EFFECT VARIABLE 5 0.0013
173 NEONATAL DISORDER 2 0.0013
174 CUSHINGOID 4 0.0012
175 LUNG INFILTRATION 11 0.0012
176 DERMATITIS BULLOUS 9 0.0012
177 ACNE PUSTULAR 1 0.0012
178 BRADYARRHYTHMIA 2 0.0012
179 INTESTINAL POLYP 2 0.0012
180 BLOOD CALCIUM ABNORMAL 2 0.0012
181 RENAL IMPAIRMENT 101 0.0012
182 SYSTEMIC CANDIDA 3 0.0012
183 CEREBRAL HAEMATOMA 4 0.0012
184 SPLEEN DISORDER 2 0.0012
185 SKIN WOUND 2 0.0012
186 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
187 BLOOD POTASSIUM INCREASED 19 0.0012
188 HYPERTENSIVE CRISIS 13 0.0012
189 APLASIA PURE RED CELL 4 0.0012
190 CATHETER SITE PAIN 3 0.0012
191 ABDOMINAL LYMPHADENOPATHY 1 0.0012
192 HYPERSENSITIVITY VASCULITIS 3 0.0011
193 EXPOSURE DURING PREGNANCY 71 0.0011
194 VERTIGO POSITIONAL 2 0.0011
195 BLOOD CREATINE INCREASED 5 0.0011
196 ANAEMIA OF CHRONIC DISEASE 1 0.0011
197 LIVER TRANSPLANT 4 0.0011
198 LOBAR PNEUMONIA 2 0.0011
199 CARDIAC FAILURE 86 0.0011
200 THROAT CLEARING 4 0.0011
201 VENTRICULAR SEPTAL DEFECT 6 0.0010
202 ATROPHY 2 0.0010
203 BICYTOPENIA 2 0.0010
204 STRIDOR 3 0.0010
205 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
206 PREMATURE BABY 30 0.0010
207 CEREBROVASCULAR DISORDER 3 0.0010
208 ARTHRODESIS 1 0.0010
209 PERIPHERAL VASCULAR DISORDER 5 0.0010
210 LIVE BIRTH 8 0.0010
211 RESPIRATORY RATE DECREASED 3 0.0010
212 ACUTE KIDNEY INJURY 146 0.0010
213 BUNDLE BRANCH BLOCK LEFT 4 0.0009
214 FOETAL DISTRESS SYNDROME 2 0.0009
215 CATHETER SITE ERYTHEMA 2 0.0009
216 OCULOGYRIC CRISIS 2 0.0009
217 GINGIVITIS 5 0.0009
218 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
219 ACARODERMATITIS 1 0.0009
220 COLONOSCOPY 2 0.0009
221 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
222 POTENTIATING DRUG INTERACTION 3 0.0009
223 HYPERTENSION 189 0.0009
224 CHRONIC GASTRITIS 2 0.0009
225 DIABETIC RETINOPATHY 3 0.0009
226 ARTERIAL HAEMORRHAGE 1 0.0009
227 HYPERBILIRUBINAEMIA 9 0.0009
228 EXERCISE TOLERANCE DECREASED 5 0.0009
229 GRANULOMA 3 0.0009
230 HEPATIC ENZYME INCREASED 59 0.0009
231 ACUTE PRERENAL FAILURE 1 0.0009
232 BLOOD PRESSURE ABNORMAL 17 0.0009
233 NEONATAL RESPIRATORY DISTRESS SYNDROME 3 0.0008
234 SYMPTOM RECURRENCE 5 0.0008
235 PAINFUL RESPIRATION 2 0.0008
236 ABDOMINAL DISCOMFORT 137 0.0008
237 HEPATOMEGALY 8 0.0008
238 PROTEIN URINE PRESENT 4 0.0008
239 DRUG-INDUCED LIVER INJURY 25 0.0008
240 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
241 URINARY TRACT INFECTION BACTERIAL 2 0.0008
242 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
243 APGAR SCORE LOW 1 0.0008
244 DRUG INTOLERANCE 75 0.0008
245 REHABILITATION THERAPY 3 0.0008
246 ASCITES 22 0.0007
247 WHITE BLOOD CELL DISORDER 2 0.0007
248 PROTEINURIA 14 0.0007
249 CARDIOMEGALY 9 0.0007
250 PLEURITIC PAIN 2 0.0007
251 ENDOTRACHEAL INTUBATION 2 0.0007
252 HALLUCINATIONS, MIXED 3 0.0007
253 SKIN REACTION 10 0.0007
254 PREMATURE LABOUR 4 0.0007
255 CARDIAC VALVE DISEASE 4 0.0007
256 DUODENAL ULCER HAEMORRHAGE 2 0.0007
257 BLOOD MAGNESIUM DECREASED 6 0.0007
258 VITAMIN B12 DECREASED 2 0.0007
259 CAESAREAN SECTION 8 0.0007
260 ANGIOPLASTY 1 0.0007
261 GASTROINTESTINAL DISORDER 60 0.0007
262 URINE ANALYSIS ABNORMAL 2 0.0007
263 ATYPICAL PNEUMONIA 2 0.0007
264 PHOTOSENSITIVITY REACTION 11 0.0007
265 VASCULAR DEVICE INFECTION 3 0.0007
266 ACUTE HEPATIC FAILURE 9 0.0007
267 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
268 ISCHAEMIA 3 0.0007
269 FIBROSIS 2 0.0006
270 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
271 CHRONIC KIDNEY DISEASE 49 0.0006
272 NEPHROPATHY 6 0.0006
273 MATERNAL EXPOSURE DURING PREGNANCY 57 0.0006
274 PRE-ECLAMPSIA 3 0.0006
275 FOREIGN BODY SENSATION IN EYES 4 0.0006
276 PROCTALGIA 4 0.0006
277 AUTOIMMUNE DISORDER 6 0.0006
278 RENAL TUBULAR NECROSIS 6 0.0006
279 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
280 RESPIRATORY FAILURE 44 0.0006
281 DYSPHORIA 3 0.0006
282 TONGUE ULCERATION 2 0.0006
283 TOE AMPUTATION 3 0.0006
284 DYSLIPIDAEMIA 3 0.0006
285 NEPHROTIC SYNDROME 4 0.0006
286 WOUND COMPLICATION 2 0.0006
287 ACUTE SINUSITIS 1 0.0006
288 LYMPHOEDEMA 4 0.0006
289 BLOOD CREATININE ABNORMAL 2 0.0006
290 VENTRICULAR EXTRASYSTOLES 6 0.0006
291 PLEURAL EFFUSION 35 0.0006
292 ACUTE RESPIRATORY FAILURE 11 0.0006
293 EAR PRURITUS 2 0.0006
294 ALOPECIA AREATA 1 0.0006
295 BLOOD LACTIC ACID INCREASED 3 0.0006
296 HEART DISEASE CONGENITAL 2 0.0006
297 APPENDICECTOMY 2 0.0006
298 PRODUCT RESIDUE PRESENT 3 0.0006
299 SPONDYLITIS 2 0.0005
300 RENAL FAILURE 73 0.0005
301 ABDOMINAL PAIN UPPER 112 0.0005
302 HYPERKERATOSIS 3 0.0005
303 ALCOHOL USE 2 0.0005
304 IRON DEFICIENCY ANAEMIA 5 0.0005
305 ANGIOPATHY 3 0.0005
306 HEPATIC NECROSIS 2 0.0005
307 PERIORBITAL SWELLING 3 0.0005
308 SPUTUM DISCOLOURED 5 0.0005
309 EYE HAEMORRHAGE 7 0.0005
310 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
311 SINUS CONGESTION 7 0.0005
312 ATELECTASIS 5 0.0005
313 ARTERIAL THROMBOSIS 1 0.0005
314 PRODUCT TASTE ABNORMAL 7 0.0005
315 RALES 3 0.0005
316 APHTHOUS ULCER 4 0.0005
317 PRODUCT LABEL CONFUSION 3 0.0005
318 HAEMORRHAGIC STROKE 4 0.0005
319 COUGH 143 0.0005
320 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
321 PATENT DUCTUS ARTERIOSUS 2 0.0005
322 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
323 GANGRENE 3 0.0005
324 FUNGAL SKIN INFECTION 2 0.0005
325 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
326 APPLICATION SITE DISCOLOURATION 2 0.0005
327 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
328 ENCEPHALOPATHY 12 0.0005
329 GENERALISED OEDEMA 6 0.0005
330 PERITONITIS 10 0.0005
331 FREQUENT BOWEL MOVEMENTS 13 0.0005
332 NASAL DRYNESS 3 0.0005
333 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 34 0.0005
334 TRANSFUSION 5 0.0005
335 MULTIPLE INJURIES 3 0.0005
336 INJECTION SITE DISCOMFORT 5 0.0005
337 SCRATCH 5 0.0005
338 ENTERITIS 3 0.0005
339 ANAEMIA MACROCYTIC 1 0.0005
340 BLOOD POTASSIUM DECREASED 14 0.0005
341 HIATUS HERNIA 6 0.0005
342 CARDIAC MURMUR 4 0.0005
343 HEPATITIS ACUTE 3 0.0005
344 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
345 BLOOD PRESSURE FLUCTUATION 11 0.0005
346 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
347 PURPURA 4 0.0005
348 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
349 NEPHROPATHY TOXIC 5 0.0004
350 IRON DEFICIENCY 2 0.0004
351 BRADYCARDIA 23 0.0004
352 LARGE INTESTINE POLYP 3 0.0004
353 DIVERTICULITIS 12 0.0004
354 BLOOD PRESSURE INCREASED 66 0.0004
355 CONJUNCTIVITIS 8 0.0004
356 HAEMOPTYSIS 12 0.0004
357 DUODENAL ULCER 3 0.0004
358 POISONING DELIBERATE 4 0.0004
359 METASTASIS 3 0.0004
360 ENDOMETRIOSIS 2 0.0004
361 HYPERLIPIDAEMIA 5 0.0004
362 KIDNEY TRANSPLANT REJECTION 2 0.0004
363 VISUAL FIELD DEFECT 3 0.0004
364 STILLBIRTH 2 0.0004
365 ADRENAL INSUFFICIENCY 5 0.0004
366 HAEMORRHOIDS 8 0.0004
367 HOSPITALISATION 63 0.0004
368 BREATH SOUNDS ABNORMAL 2 0.0004
369 LIGAMENT SPRAIN 4 0.0004
370 ACUTE PSYCHOSIS 1 0.0004
371 FEELING DRUNK 3 0.0004
372 PULMONARY MASS 6 0.0004
373 ABDOMINAL TENDERNESS 2 0.0004
374 PULMONARY OEDEMA 18 0.0004
375 ANEURYSM 2 0.0004
376 HAEMORRHAGE INTRACRANIAL 6 0.0004
377 HYDRONEPHROSIS 3 0.0004
378 RENAL FAILURE ACUTE 17 0.0004
379 VEIN DISORDER 2 0.0004
380 ABDOMINAL PAIN 92 0.0004
381 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
382 CORONARY ARTERIAL STENT INSERTION 2 0.0004
383 TROPONIN INCREASED 3 0.0004
384 EYELID PTOSIS 4 0.0004
385 APPENDICITIS PERFORATED 1 0.0004
386 ABDOMINAL INFECTION 1 0.0004
387 PRODUCT COLOUR ISSUE 2 0.0004
388 AORTIC ARTERIOSCLEROSIS 1 0.0004
389 PRODUCT USE ISSUE 73 0.0004
390 FOETAL DEATH 2 0.0004
391 PULMONARY CONGESTION 5 0.0004
392 DECREASED ACTIVITY 4 0.0004
393 RENAL INJURY 11 0.0004
394 CHEST PAIN 68 0.0004
395 HYDROCEPHALUS 2 0.0004
396 HYPERSENSITIVITY 68 0.0004
397 APPLICATION SITE HAEMORRHAGE 1 0.0004
398 ARTHRALGIA 152 0.0004
399 HICCUPS 3 0.0004
400 ASPIRATION 4 0.0004
401 HYPERAESTHESIA 3 0.0004
402 HYPOTENSION 73 0.0004
403 INTESTINAL ISCHAEMIA 2 0.0004
404 ACUTE CORONARY SYNDROME 3 0.0004
405 MENTAL STATUS CHANGES 10 0.0004
406 HEPATOTOXICITY 8 0.0004
407 INTRACRANIAL PRESSURE INCREASED 2 0.0004
408 HEART RATE ABNORMAL 2 0.0004
409 HAEMODIALYSIS 3 0.0004
410 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
411 DYSPNOEA 199 0.0004
412 MALAISE 154 0.0004
413 INTENTIONAL DOSE OMISSION 10 0.0004
414 PARALYSIS 5 0.0003
415 CARDIAC OPERATION 3 0.0003
416 ANURIA 3 0.0003
417 PYELONEPHRITIS 3 0.0003
418 ORTHOSTATIC HYPOTENSION 6 0.0003
419 METABOLIC ACIDOSIS 11 0.0003
420 FLUID OVERLOAD 5 0.0003
421 RENAL DISORDER 16 0.0003
422 ABORTION 1 0.0003
423 GROIN PAIN 3 0.0003
424 IMMUNOSUPPRESSION 3 0.0003
425 DECREASED INTEREST 2 0.0003
426 ENERGY INCREASED 2 0.0003
427 DRUG ERUPTION 6 0.0003
428 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
429 OEDEMA PERIPHERAL 41 0.0003
430 IMMUNODEFICIENCY 5 0.0003
431 PROTHROMBIN TIME PROLONGED 2 0.0003
432 HEPATITIS CHOLESTATIC 2 0.0003
433 TREATMENT NONCOMPLIANCE 18 0.0003
434 RETCHING 7 0.0003
435 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
436 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
437 SPINAL OPERATION 4 0.0003
438 LARYNGEAL OEDEMA 2 0.0003
439 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
440 ILEUS 4 0.0003
441 COGNITIVE DISORDER 15 0.0003
442 DISEASE PROGRESSION 38 0.0003
443 ATRIAL FIBRILLATION 31 0.0003
444 INFUSION SITE SWELLING 2 0.0003
445 DIARRHOEA 205 0.0003
446 PRODUCT USE COMPLAINT 5 0.0003
447 ABDOMINAL ADHESIONS 1 0.0003
448 ANGIOEDEMA 14 0.0003
449 HALLUCINATION, AUDITORY 5 0.0003
450 ABSCESS 5 0.0003
451 HERPES SIMPLEX 2 0.0003
452 CONSTIPATION 67 0.0003
453 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
454 TINNITUS 14 0.0003
455 BEDRIDDEN 4 0.0003
456 HOSPICE CARE 3 0.0003
457 ANAEMIA 57 0.0003
458 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
459 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
460 BRONCHIECTASIS 2 0.0003
461 POSTOPERATIVE WOUND INFECTION 2 0.0003
462 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
463 SLUGGISHNESS 3 0.0003
464 ABNORMAL LOSS OF WEIGHT 2 0.0003
465 INFARCTION 2 0.0003
466 HAIR GROWTH ABNORMAL 2 0.0003
467 AORTIC STENOSIS 1 0.0003
468 WEIGHT FLUCTUATION 3 0.0003
469 BLOOD PRESSURE DECREASED 19 0.0003
470 APPLICATION SITE REACTION 2 0.0003
471 FOETAL EXPOSURE DURING PREGNANCY 23 0.0003
472 SEASONAL ALLERGY 4 0.0003
473 EATING DISORDER 6 0.0003
474 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
475 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
476 CONTUSION 27 0.0003
477 PHARYNGITIS STREPTOCOCCAL 3 0.0003
478 OSTEOMYELITIS 5 0.0003
479 RASH 120 0.0003
480 DISEASE RECURRENCE 13 0.0003
481 CEREBRAL DISORDER 2 0.0003
482 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
483 ARTHROPOD BITE 2 0.0003
484 SYNCOPE 27 0.0003
485 PANCYTOPENIA 15 0.0003
486 HEPATIC CIRRHOSIS 5 0.0003
487 HEART RATE IRREGULAR 6 0.0003
488 REBOUND EFFECT 3 0.0003
489 MITRAL VALVE INCOMPETENCE 3 0.0003
490 LACRIMATION INCREASED 8 0.0003
491 POLLAKIURIA 11 0.0003
492 PRODUCT AVAILABILITY ISSUE 6 0.0003
493 LIPASE INCREASED 2 0.0003
494 SHOCK 6 0.0003
495 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
496 POST PROCEDURAL COMPLICATION 5 0.0003
497 RENAL FAILURE CHRONIC 2 0.0003
498 FOOD ALLERGY 2 0.0003
499 ATRIOVENTRICULAR BLOCK 2 0.0003
500 PRESCRIBED OVERDOSE 5 0.0003
501 HYPOALBUMINAEMIA 2 0.0003
502 DYSPHONIA 15 0.0003
503 THERAPY PARTIAL RESPONDER 4 0.0003
504 HEART RATE DECREASED 9 0.0003
505 PALPITATIONS 30 0.0003
506 BRAIN FOG 4 0.0003
507 MULTIPLE ALLERGIES 2 0.0003
508 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
509 ARTHRITIS 20 0.0003
510 RESPIRATORY DISTRESS 7 0.0003
511 BLOOD IRON DECREASED 3 0.0003
512 BACTERAEMIA 3 0.0003
513 RENAL CYST 2 0.0003
514 CHOLECYSTITIS 3 0.0003
515 ULCER 4 0.0003
516 THROMBOCYTOPENIA 28 0.0003
517 BLOOD DISORDER 2 0.0002
518 FULL BLOOD COUNT DECREASED 5 0.0002
519 PRODUCT PHYSICAL ISSUE 5 0.0002
520 FRUSTRATION TOLERANCE DECREASED 2 0.0002
521 MUSCLE DISORDER 2 0.0002
522 COLITIS ULCERATIVE 11 0.0002
523 SHOCK HAEMORRHAGIC 2 0.0002
524 RESPIRATORY DEPRESSION 3 0.0002
525 ARTHRITIS BACTERIAL 1 0.0002
526 HAEMOGLOBIN DECREASED 25 0.0002
527 TENDON RUPTURE 3 0.0002
528 ILLNESS 25 0.0002
529 SEPSIS 27 0.0002
530 BLOOD UREA INCREASED 4 0.0002
531 ATRIAL SEPTAL DEFECT 2 0.0002
532 PERICARDITIS 4 0.0002
533 MUSCLE ATROPHY 3 0.0002
534 URINARY INCONTINENCE 7 0.0002
535 HEMIPARESIS 4 0.0002
536 VITAMIN D DECREASED 2 0.0002
537 NAUSEA 184 0.0002
538 UNRESPONSIVE TO STIMULI 6 0.0002
539 PSYCHOLOGICAL TRAUMA 2 0.0002
540 MYOPATHY 2 0.0002
541 TOXICITY TO VARIOUS AGENTS 39 0.0002
542 CORONARY ARTERY DISEASE 7 0.0002
543 DRUG DOSE OMISSION 38 0.0002
544 HEADACHE 143 0.0002
545 BLOOD CALCIUM INCREASED 2 0.0002
546 SPINAL OSTEOARTHRITIS 2 0.0002
547 GRIP STRENGTH DECREASED 2 0.0002
548 LIMB DISCOMFORT 7 0.0002
549 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
550 ISCHAEMIC STROKE 4 0.0002
551 SWOLLEN TONGUE 7 0.0002
552 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
553 PNEUMONIA 72 0.0002
554 BONE PAIN 13 0.0002
555 GASTROENTERITIS VIRAL 4 0.0002
556 OROPHARYNGEAL DISCOMFORT 2 0.0002
557 OEDEMA 12 0.0002
558 IMPAIRED GASTRIC EMPTYING 3 0.0002
559 OFF LABEL USE 191 0.0002
560 HYPOKALAEMIA 10 0.0002
561 PROCEDURAL PAIN 6 0.0002
562 RHABDOMYOLYSIS 9 0.0002
563 HYPOMAGNESAEMIA 3 0.0002
564 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
565 AGRANULOCYTOSIS 4 0.0002
566 ARTERIOSCLEROSIS 2 0.0002
567 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
568 ASTHENIA 79 0.0002
569 FEELING JITTERY 4 0.0002
570 EYE INFLAMMATION 2 0.0002
571 SLEEP APNOEA SYNDROME 4 0.0002
572 GAIT INABILITY 7 0.0002
573 INCREASED APPETITE 4 0.0002
574 HYPERSOMNIA 6 0.0002
575 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
576 LETHARGY 12 0.0002
577 AFFECT LABILITY 2 0.0002
578 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
579 SINUS BRADYCARDIA 2 0.0002
580 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
581 KIDNEY INFECTION 4 0.0002
582 VITREOUS FLOATERS 2 0.0002
583 HAEMATOCRIT DECREASED 4 0.0002
584 SWELLING FACE 13 0.0002
585 BLOOD CREATININE INCREASED 13 0.0002
586 CELLULITIS 10 0.0002
587 ECONOMIC PROBLEM 3 0.0002
588 MEDICATION ERROR 11 0.0002
589 HYPOTHERMIA 2 0.0002
590 CARDIOVASCULAR DISORDER 5 0.0002
591 DRY THROAT 2 0.0002
592 DRUG DISPENSING ERROR 3 0.0002
593 AMMONIA INCREASED 1 0.0002
594 CEREBRAL HAEMORRHAGE 7 0.0002
595 DEHYDRATION 26 0.0002
596 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
597 OSTEOPOROSIS 8 0.0002
598 TEMPERATURE INTOLERANCE 2 0.0002
599 TENDONITIS 3 0.0002
600 POOR VENOUS ACCESS 2 0.0002
601 LUNG INFECTION 3 0.0002
602 HAEMATOMA 5 0.0002
603 EYE DISCHARGE 2 0.0002
604 PETECHIAE 2 0.0002
605 APLASTIC ANAEMIA 1 0.0002
606 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
607 PRODUCTIVE COUGH 9 0.0002
608 PERIPHERAL SWELLING 29 0.0002
609 ANORECTAL DISCOMFORT 1 0.0002
610 CHILLS 22 0.0002
611 SURGERY 11 0.0002
612 BREAST PAIN 2 0.0002
613 INFECTION 27 0.0002
614 DIZZINESS 93 0.0002
615 DYSARTHRIA 7 0.0002
616 FEAR 5 0.0002
617 INTERSTITIAL LUNG DISEASE 9 0.0002
618 SKIN CANCER 4 0.0002
619 HYPOGLYCAEMIA 9 0.0002
620 THROAT TIGHTNESS 5 0.0002
621 LIMB INJURY 5 0.0002
622 SKIN LACERATION 2 0.0002
623 SEPTIC SHOCK 8 0.0002
624 PRODUCT DOSE OMISSION 12 0.0002
625 DIABETES MELLITUS 14 0.0002
626 PULMONARY THROMBOSIS 2 0.0002
627 CEREBROVASCULAR ACCIDENT 31 0.0002
628 WOUND INFECTION 2 0.0002
629 THERAPEUTIC RESPONSE DECREASED 11 0.0002
630 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
631 VENTRICULAR FIBRILLATION 2 0.0002
632 COMPLETED SUICIDE 15 0.0002
633 SKIN DISORDER 6 0.0002
634 DEMENTIA 5 0.0002
635 BLOOD CALCIUM DECREASED 2 0.0002
636 EYE INFECTION 2 0.0002
637 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
638 SCAR 3 0.0002
639 MICTURITION URGENCY 2 0.0002
640 CHOLECYSTECTOMY 2 0.0002
641 ANGINA PECTORIS 5 0.0002
642 MUSCULOSKELETAL DISCOMFORT 3 0.0002
643 MULTI-ORGAN FAILURE 3 0.0002
644 GAIT DISTURBANCE 33 0.0002
645 SPLENOMEGALY 2 0.0002
646 INJURY 12 0.0002
647 MYALGIA 29 0.0002
648 DRUG INTERACTION 27 0.0002
649 NASAL CONGESTION 10 0.0002
650 LABORATORY TEST ABNORMAL 5 0.0002
651 ARRHYTHMIA 8 0.0002
652 ATAXIA 2 0.0002
653 GALLBLADDER DISORDER 3 0.0002
654 CATARACT 10 0.0002
655 BACK PAIN 39 0.0002
656 FLUSHING 17 0.0002
657 MOBILITY DECREASED 12 0.0002
658 PAIN 102 0.0002
659 LEUKOCYTOSIS 3 0.0002
660 LOCALISED INFECTION 4 0.0002
661 NEURALGIA 4 0.0002
662 URINARY TRACT INFECTION 28 0.0002
663 DISCOMFORT 10 0.0002
664 CEREBRAL INFARCTION 4 0.0002
665 LIVER INJURY 4 0.0002
666 DEPRESSION 37 0.0002
667 ABNORMAL WEIGHT GAIN 2 0.0002
668 ABASIA 4 0.0002
669 THROMBOSIS 13 0.0002
670 WEIGHT DECREASED 45 0.0002
671 TOOTH EXTRACTION 2 0.0002
672 EPISTAXIS 12 0.0002
673 PNEUMONIA ASPIRATION 4 0.0002
674 INJECTION SITE DISCOLOURATION 2 0.0002
675 HYPONATRAEMIA 9 0.0002
676 HYPOCALCAEMIA 3 0.0002
677 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
678 FLUID RETENTION 8 0.0002
679 CYSTITIS 5 0.0002
680 HERPES ZOSTER 9 0.0002
681 LOWER LIMB FRACTURE 3 0.0002
682 MYDRIASIS 2 0.0002
683 INFUSION SITE PAIN 2 0.0002
684 ANOREXIA 2 0.0002
685 ANGINA UNSTABLE 1 0.0002
686 MUCOSAL INFLAMMATION 4 0.0002
687 SEDATION 4 0.0002
688 IMPAIRED HEALING 5 0.0002
689 GASTRITIS 4 0.0002
690 IMMUNE SYSTEM DISORDER 2 0.0002
691 OROPHARYNGEAL PAIN 14 0.0002
692 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
693 APPETITE DISORDER 1 0.0002
694 DECREASED APPETITE 35 0.0002
695 UPPER LIMB FRACTURE 3 0.0002
696 INJECTION SITE BRUISING 12 0.0002
697 FALL 50 0.0002
698 CARDIAC DISORDER 14 0.0001
699 SWELLING 14 0.0001
700 MUSCULAR WEAKNESS 17 0.0001
701 HAIR TEXTURE ABNORMAL 2 0.0001
702 JOINT RANGE OF MOTION DECREASED 2 0.0001
703 BLOOD BILIRUBIN INCREASED 4 0.0001
704 TASTE DISORDER 3 0.0001
705 NEUROPATHY PERIPHERAL 14 0.0001
706 TACHYPNOEA 2 0.0001
707 CHEST DISCOMFORT 15 0.0001
708 TACHYCARDIA 13 0.0001
709 VISION BLURRED 20 0.0001
710 ANAPHYLACTIC REACTION 8 0.0001
711 NIGHTMARE 5 0.0001
712 FEELING COLD 4 0.0001
713 CARDIO-RESPIRATORY ARREST 6 0.0001
714 COORDINATION ABNORMAL 2 0.0001
715 LUNG DISORDER 7 0.0001
716 CARPAL TUNNEL SYNDROME 2 0.0001
717 OXYGEN SATURATION DECREASED 8 0.0001
718 FLATULENCE 8 0.0001
719 JOINT INJURY 3 0.0001
720 INTENTIONAL OVERDOSE 9 0.0001
721 FATIGUE 109 0.0001
722 RED BLOOD CELL COUNT DECREASED 4 0.0001
723 SUBDURAL HAEMATOMA 2 0.0001
724 CARDIOGENIC SHOCK 2 0.0001
725 IMPAIRED QUALITY OF LIFE 2 0.0001
726 BALANCE DISORDER 12 0.0001
727 PRURITUS GENERALISED 3 0.0001
728 FAECES DISCOLOURED 3 0.0001
729 DRUG INEFFECTIVE 182 0.0001
730 MYOCARDIAL INFARCTION 24 0.0001
731 SINUSITIS 14 0.0001
732 MELAENA 3 0.0001
733 CARDIOMYOPATHY 2 0.0001
734 BRONCHITIS 10 0.0001
735 SKIN HAEMORRHAGE 2 0.0001
736 TOOTH DISORDER 3 0.0001
737 THROAT IRRITATION 6 0.0001
738 RESPIRATORY DISORDER 4 0.0001
739 INTESTINAL OBSTRUCTION 5 0.0001
740 SUICIDE ATTEMPT 8 0.0001
741 OSTEOPENIA 2 0.0001
742 COVID-19 23 0.0001
743 ACIDOSIS 1 0.0001
744 CONFUSIONAL STATE 21 0.0001
745 VISUAL IMPAIRMENT 16 0.0001
746 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
747 BURNING SENSATION 9 0.0001
748 ACUTE MYELOID LEUKAEMIA 2 0.0001
749 BASAL CELL CARCINOMA 2 0.0001
750 BLOOD GLUCOSE INCREASED 24 0.0001
751 AFFECTIVE DISORDER 1 0.0001
752 HYPOAESTHESIA 19 0.0001
753 HAEMATOCHEZIA 7 0.0001
754 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
755 PNEUMOTHORAX 2 0.0001
756 COMA 6 0.0001
757 VOMITING 59 0.0001
758 FEELING ABNORMAL 30 0.0001
759 SENSORY DISTURBANCE 2 0.0001
760 ABDOMINAL DISTENSION 13 0.0001
761 LACTIC ACIDOSIS 4 0.0001
762 PRESYNCOPE 3 0.0001
763 DRY MOUTH 10 0.0001
764 DYSKINESIA 5 0.0001
765 AMNESIA 8 0.0001
766 ABNORMAL FAECES 1 0.0001
767 CARDIAC ARREST 10 0.0001
768 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
769 TREMOR 20 0.0001
770 DRY EYE 6 0.0001
771 VIRAL INFECTION 4 0.0001
772 LIP SWELLING 4 0.0001
773 FUNGAL INFECTION 4 0.0001
774 UNEVALUABLE EVENT 9 0.0001
775 PAIN IN EXTREMITY 35 0.0001
776 CANDIDA INFECTION 2 0.0001
777 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
778 WHEEZING 7 0.0001
779 OSTEOARTHRITIS 5 0.0001
780 LOSS OF CONSCIOUSNESS 15 0.0001
781 DYSPHAGIA 11 0.0001
782 RESPIRATORY TRACT INFECTION 3 0.0001
783 ASTHMA 13 0.0001
784 NERVOUSNESS 6 0.0001
785 ECZEMA 6 0.0001
786 MUSCULOSKELETAL PAIN 6 0.0001
787 PRURITUS 44 0.0001
788 ANHEDONIA 3 0.0001
789 NEUROTOXICITY 2 0.0001
790 METASTASES TO LIVER 2 0.0001
791 HYPOXIA 4 0.0001
792 DEPRESSED MOOD 6 0.0001
793 SLEEP DISORDER 8 0.0001
794 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
795 HEAD DISCOMFORT 2 0.0001
796 ANXIETY 32 0.0001
797 ERYTHEMA 23 0.0001
798 THERAPY NON-RESPONDER 5 0.0001
799 HEART RATE INCREASED 11 0.0001
800 RASH PRURITIC 6 0.0001
801 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
802 TOOTHACHE 2 0.0001
803 PNEUMONITIS 3 0.0001
804 HYPERGLYCAEMIA 4 0.0001
805 BONE DISORDER 2 0.0001
806 SKIN LESION 3 0.0001
807 MUSCLE SPASMS 20 0.0001
808 SKIN DISCOLOURATION 5 0.0001
809 RHINORRHOEA 7 0.0001
810 DEEP VEIN THROMBOSIS 7 0.0001
811 JOINT SWELLING 13 0.0001
812 BACTERIAL INFECTION 2 0.0001
813 APPENDICITIS 1 0.0001
814 EYE PAIN 6 0.0001
815 DYSPNOEA EXERTIONAL 4 0.0001
816 BLOOD SODIUM DECREASED 2 0.0001
817 COLITIS 4 0.0001
818 FOOT FRACTURE 2 0.0001
819 OCULAR HYPERAEMIA 5 0.0001
820 CONDITION AGGRAVATED 32 0.0001
821 RASH ERYTHEMATOUS 5 0.0001
822 SOMNOLENCE 21 0.0001
823 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
824 BLOOD GLUCOSE DECREASED 5 0.0001
825 DRUG PRESCRIBING ERROR 2 0.0001
826 SEIZURE 12 0.0001
827 HERNIA 2 0.0001
828 NASOPHARYNGITIS 19 0.0001
829 EAR PAIN 2 0.0001
830 WEIGHT INCREASED 23 0.0001
831 CHOKING 2 0.0001
832 MEMORY IMPAIRMENT 14 0.0001
833 ACUTE MYOCARDIAL INFARCTION 3 0.0001
834 PARAESTHESIA 16 0.0001
835 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
836 SINUS DISORDER 2 0.0001
837 PRODUCT ADMINISTRATION ERROR 2 0.0001
838 INSOMNIA 26 0.0001
839 INFLAMMATION 5 0.0001
840 FEMUR FRACTURE 3 0.0001
841 NERVOUS SYSTEM DISORDER 3 0.0001
842 PULMONARY HYPERTENSION 2 0.0001
843 PRODUCT DOSE OMISSION ISSUE 28 0.0001
844 SKIN EXFOLIATION 8 0.0001
845 HEAD INJURY 3 0.0001
846 HALLUCINATION, VISUAL 2 0.0001
847 HYPOTHYROIDISM 3 0.0001
848 MOVEMENT DISORDER 3 0.0001
849 LIVER FUNCTION TEST INCREASED 2 0.0001
850 RECTAL HAEMORRHAGE 4 0.0001
851 DEATH 80 0.0001
852 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
853 MENTAL DISORDER 4 0.0001
854 PRODUCT DISPENSING ERROR 2 0.0001
855 CHOLELITHIASIS 3 0.0001
856 EYE DISORDER 3 0.0001
857 STEVENS-JOHNSON SYNDROME 2 0.0001
858 TRANSAMINASES INCREASED 2 0.0001
859 URINARY RETENTION 3 0.0001
860 RASH MACULO-PAPULAR 2 0.0001
861 INJECTION SITE PRURITUS 6 0.0001
862 ORAL PAIN 2 0.0001
863 SNEEZING 2 0.0001
864 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
865 TYPE 2 DIABETES MELLITUS 3 0.0001
866 ADVERSE DRUG REACTION 8 0.0001
867 BLISTER 5 0.0001
868 CHROMATURIA 2 0.0001
869 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
870 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
871 DELIRIUM 3 0.0001
872 HAEMORRHAGE 9 0.0001
873 BLOOD CHOLESTEROL INCREASED 4 0.0001
874 PLATELET COUNT DECREASED 9 0.0001
875 MULTIPLE SCLEROSIS 4 0.0001
876 URTICARIA 14 0.0001
877 STOMATITIS 5 0.0001
878 RESTLESSNESS 3 0.0001
879 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
880 PYREXIA 28 0.0001
881 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
882 HEPATIC FUNCTION ABNORMAL 3 0.0001
883 AGEUSIA 2 0.0001
884 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
885 HOT FLUSH 6 0.0001
886 INJECTION SITE SWELLING 6 0.0001
887 HEPATITIS 2 0.0001
888 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
889 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
890 HYPERHIDROSIS 10 0.0001
891 SKIN ULCER 2 0.0001
892 DIPLOPIA 2 0.0001
893 PLASMA CELL MYELOMA 3 0.0001
894 SPEECH DISORDER 4 0.0001
895 ANKYLOSING SPONDYLITIS 1 0.0001
896 DISORIENTATION 3 0.0001
897 PANCREATITIS 4 0.0001
898 ADVERSE REACTION 1 0.0001
899 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
900 JAUNDICE 2 0.0001
901 BLINDNESS 3 0.0001
902 NEUTROPHIL COUNT DECREASED 3 0.0001
903 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
904 ABNORMAL DREAMS 2 0.0001
905 INFLUENZA 8 0.0001
906 APHONIA 1 0.0001
907 NECK PAIN 4 0.0001
908 WOUND 2 0.0001
909 EYE IRRITATION 4 0.0001
910 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
911 ANOSMIA 1 0.0001
912 LIVER FUNCTION TEST ABNORMAL 2 0.0001
913 NEEDLE ISSUE 2 0.0001
914 APATHY 1 0.0001
915 INTENTIONAL PRODUCT MISUSE 6 0.0001
916 MUSCULOSKELETAL STIFFNESS 6 0.0001
917 AGITATION 5 0.0001
918 DRY SKIN 9 0.0001
919 HEPATIC FAILURE 2 0.0001
920 PRODUCT QUALITY ISSUE 9 0.0001
921 NO ADVERSE EVENT 12 0.0001
922 ILL-DEFINED DISORDER 4 0.0001
923 NEPHROLITHIASIS 3 0.0001
924 EMOTIONAL DISORDER 2 0.0001
925 ANKLE FRACTURE 1 0.0001
926 RENAL CANCER 3 0.0001
927 HIP FRACTURE 2 0.0001
928 NIGHT SWEATS 2 0.0001
929 VISUAL ACUITY REDUCED 2 0.0001
930 LEUKOPENIA 3 0.0001
931 EYE PRURITUS 2 0.0001
932 NEUTROPENIA 8 0.0001
933 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
934 EMOTIONAL DISTRESS 7 0.0001
935 DEVICE USE ERROR 2 0.0001
936 AMENORRHOEA 1 0.0001
937 LYMPHADENOPATHY 2 0.0001
938 THERAPY INTERRUPTED 4 0.0001
939 OVERDOSE 12 0.0001
940 CRYING 2 0.0001
941 C-REACTIVE PROTEIN INCREASED 2 0.0001
942 PANIC ATTACK 2 0.0001
943 DYSURIA 2 0.0001
944 ADVERSE EVENT 5 0.0001
945 INJECTION SITE MASS 2 0.0001
946 ARTHROPATHY 3 0.0001
947 DYSGEUSIA 4 0.0001
948 EYE SWELLING 2 0.0001
949 HALLUCINATION 4 0.0001
950 CONVULSION 3 0.0001
951 MIGRAINE 5 0.0001
952 PRODUCT SUBSTITUTION ISSUE 3 0.0001
953 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
954 ABNORMAL BEHAVIOUR 2 0.0001
955 VERTIGO 3 0.0000
956 FEELING HOT 3 0.0000
957 LUNG NEOPLASM MALIGNANT 2 0.0000
958 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
959 ROAD TRAFFIC ACCIDENT 2 0.0000
960 VAGINAL HAEMORRHAGE 2 0.0000
961 ALOPECIA 9 0.0000
962 DEVICE DIFFICULT TO USE 3 0.0000
963 NEOPLASM MALIGNANT 3 0.0000
964 APPLICATION SITE PRURITUS 1 0.0000
965 DEVICE MALFUNCTION 3 0.0000
966 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
967 INCORRECT DOSE ADMINISTERED 9 0.0000
968 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
969 THERAPY CESSATION 2 0.0000
970 DRUG DOSE OMISSION BY DEVICE 3 0.0000
971 PSORIASIS 5 0.0000
972 INJECTION SITE HAEMORRHAGE 3 0.0000
973 DRUG EFFECT DECREASED 2 0.0000
974 DISTURBANCE IN ATTENTION 2 0.0000
975 INFLUENZA LIKE ILLNESS 3 0.0000
976 TREATMENT FAILURE 3 0.0000
977 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
978 IRRITABILITY 2 0.0000
979 INJECTION SITE ERYTHEMA 4 0.0000
980 PULMONARY EMBOLISM 3 0.0000
981 DYSPEPSIA 3 0.0000
982 INFUSION RELATED REACTION 2 0.0000
983 ANGER 1 0.0000
984 INJECTION SITE PAIN 9 0.0000
985 INJECTION SITE REACTION 2 0.0000
986 UNDERDOSE 2 0.0000
987 ACCIDENTAL OVERDOSE 1 0.0000
988 ACNE 2 0.0000
989 DEVICE ISSUE 2 0.0000
990 AGGRESSION 1 0.0000
991 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
992 DRUG DEPENDENCE 2 0.0000